CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 2a, Single Dose, Open-label, Dose Exploration Study to Assess the PK-PD Activity, Safety, and Tolerability of GSK4532990 in Adult. Participants With NASH or Suspected NASH

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06104319
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-10-28T01:07:04.606208+00:00
Published At: 2026-10-27T00:00:00+00:00
Record Updated At: 2026-10-27
Results Posted At: 2026-10-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-alcoholic Fatty Liver Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-10-27"
protocolSection.identificationModule.nctId: "NCT06104319"
protocolSection.identificationModule.officialTitle: "A Phase 2a, Single Dose, Open-label, Dose Exploration Study to Assess the PK-PD Activity, Safety, and Tolerability of GSK4532990 in Adult. Participants With NASH or Suspected NASH"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-10-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.